ANDREW QUINN: Open Payments
NPI 1588044978 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 12 payments from 6 companies in 2025. Trend: 2023 $266 · 2024 $238 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Amgen Inc. | 3 | $53 |
| GENZYME CORPORATION | 3 | $47 |
| UCB, Inc. | 1 | $47 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
Products named: COSENTYX, OTEZLA, DUPIXENT, Bimzelx, RINVOQ, EBGLYSS.
Industry payments across TX — which companies pay providers there.
